ArticleTransgenic research2026
Generation and characterization of the Il11-Cre knock-in mouse.
Article in Transgenic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Interleukin-11 (Il11) is a cytokine that belongs to the IL-6 family and is involved in inflammation, fibrosis, cancer, and ageing. Here, we generated an Il11-Cre knock-in mouse line and crossed it with the R26-tdTomato reporter to label and track of Il11-positive cells and their descendants under both developmental and pathological conditions. Using multicolor immunofluorescence staining, we identified tdTomato cells in various cell types, including fibroblasts and osteoblasts in bone, neurons in brain, enteroendocrine cells and fibroblasts in the gastrointestinal tract, pancreatic β-cells, and serous acinar cells in the submandibular glands. Notably, we observed a significant increase in fibroblasts labelled by tdTomato in a colitis model. These results indicate that this Il11-Cre line can serve as a useful genetic tool for genetic manipulation studies based on the Cre-loxp system in the aforementioned cells.
Indexed as
Identifiers
41945189What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.